Roadman Investments Appoints Pharma-based Executive Shawn Moniz to Board of Directors
VANCOUVER, British Columbia –TheNewswire -December 7, 2020 - Roadman Investments Corp. (TSXV:LITT) (FWB:1QD) (OTC:RMANF) ("Roadman Investments'' or the "Company") a Canadian Venture Capital and Advisory Firm, is pleased to announce that Shawn Moniz has been appointed to the Company’s Board of Directors effective immediately.
Luke Montaine, CEO of Roadman Investments commented, "We are excited to have Shawn Moniz join our Board of Directors, and look forward to integrating his deep knowledge of the pharmaceutical industry into our Company. His extensive knowledge of the US and Canadian pharmaceutical space in regards to marketing strategies, product development and consumer behavioural analysis will go a long way in adding value to our initiatives for 2021 and beyond.” Shawn Moniz commented, “I’m very pleased and excited to have joined the team at Roadman Investments, and I am especially looking forward to working with the Clov BioPharma team. I see great untapped potential in this company's ability to productize its Cedar Leaf Oil into the mass production wheel of sanitation products for today's clean conscience consumer. I look forward to leveraging my experience in working with Dr James Hudson, and the larger team at Roadman”.
Shawn Moniz Shawn is currently the CEO ofPlant & Co. Brands Inc., a public company trading on the Canadian Securities Exchange (“CSE”) under the symbol:VEGN. Shawn also sits on various technology advisory boards as he continues to be involved in entrepreneur-based initiatives spanning various verticals, pharmaceutical included.
Shawn has worked with the Pharma industry for over 20 years, most recently with Klick Health, Canada Largest Health Sciences Agency. In his career, Shawn has worked with almost every major player in the Canada and US pharmaceutical Markets developing and strategizing multi-million dollar consumer programs. Most notably, his career client list includes AstraZeneca, Pfizer, Astellas, Takeda, Navartis, Nova nordisk, Edna, UCB, Shire, Merk, Baxter, https://www.otcmarkets.com/stock/RMANF/news/story?e&id=1759978